---
title: "Enzon Extends Rights Plan and Preferred Stock Exchange"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/278728210.md"
description: "Enzon Extends Rights Plan and Preferred Stock Exchange"
datetime: "2026-03-11T13:03:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/278728210.md)
  - [en](https://longbridge.com/en/news/278728210.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/278728210.md)
generator: "portal-rs"
---

# Enzon Extends Rights Plan and Preferred Stock Exchange

Enzon Extends Rights Plan and Preferred Stock Exchange

### Related Stocks

- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [ENZ.US](https://longbridge.com/en/quote/ENZ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [VRTX.US](https://longbridge.com/en/quote/VRTX.US.md)
- [LABD.US](https://longbridge.com/en/quote/LABD.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [ENZB.US](https://longbridge.com/en/quote/ENZB.US.md)

## Related News & Research

- [Set Yourself Up for a Strong 2027: 2 Pharmaceutical Stocks to Buy in September](https://longbridge.com/en/news/298712103.md)
- [Vertex (VRTX) Stock Still Looks Like A Bargain On Its 181% Run](https://longbridge.com/en/news/298484320.md)
- [Vertex Pharma EVP Jasper van Grunsven files initial beneficial ownership statement](https://longbridge.com/en/news/298639785.md)
- [Sacituzumab Govitecan Plus Pembrolizumab Does Not Meet Primary Endpoints in First-Line PD-L1-High Metastatic NSCLC](https://longbridge.com/en/news/298830378.md)
- [TRDA: Upcoming clinical data and platform safety position the company for accelerated approval and market growth](https://longbridge.com/en/news/298492693.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**